# OnCo record atx-898 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/atx-898/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "atx-898" ;
  schema:name "ATX-898"@en ;
  schema:description "ATX-898 is an experimental small molecule from Antares Therapeutics, in phase 1 trials for advanced solid tumours, platinum-resistant ovarian cancer and other gynaecological cancers and other cancers."@en ;
  schema:url <https://onco.cc/drugs/atx-898/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/api/v2/studies/NCT07767474>, <https://clinicaltrials.gov/api/v2/studies/NCT07767474>, <https://clinicaltrials.gov/api/v2/studies/NCT07767474>, <https://antaresrx.com/>, <https://clinicaltrials.gov/search?intr=ATX-898> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (registry lists it as a drug; the company does not publish the modality for this code)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/antares-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07767474/> .